Universal Technical Institute, Inc. research snapshot
UTI AI stock analysis currently reads Universal Technical Institute as a for-profit postsecondary education company operating 15 UTI-branded technical campuses and 18 Concorde Career Colleges campuses nationwide. The July 10, 2026 quote was $48.45 and the calculated market capitalization was $2.67 billion. Fiscal year revenue reached $835.62 million with $63.02 million in net income, though Q2 2026 (March quarter) earnings of $0.01 per share missed consensus estimates widely. The stock has gained 86% year to date and trades near its all-time high of $51.34, reflecting optimism about skilled-trades enrollment demand. The key questions are whether enrollment growth can sustain the current premium valuation of 64x trailing earnings and whether margins can improve from the compressed Q2 level. This UTI AI stock analysis is informational only and is not investment advice.
Current price
$48.45
Market cap
$2.67 billion calculated market cap, from $48.45 price and 55.06 million shares
AI score
62 / 100
Rating
Skilled-trades and healthcare education provider with strong enrollment trends but high P/E, margin pressure, and earnings volatility to monitor
Trend status
Bullish uptrend with the stock near its all-time high of $51.34, up 86% year to date
Data cutoff (updated weekly)
July 13, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | UTI provides technical training for automotive, diesel, collision repair, welding, and skilled trades through 15 campuses, plus allied health and nursing programs through 18 Concorde campuses. Revenue is tuition-driven with high operating leverage. | Medium |
| Moat | Brand recognition in automotive technical education, campus footprint, industry employer partnerships (manufacturer relationships), and accreditation create some barriers. However, competitors include community colleges, other for-profit schools, online alternatives, and apprenticeship programs. | Low-medium |
| Management | CEO Jerome Grant has led the company since 2019, overseeing the Concorde acquisition and campus expansion. Capital allocation centers on campus openings, curriculum development, and marketing investment. Recent earnings shortfalls raise execution questions. | Medium |
| Financial trend | Revenue grew to $835.62 million (FY ending September 2025) with net income of $63.02 million. Q2 2026 revenue was $221.4 million but net income collapsed to $433K, well below expectations, driven by higher operating expenses. | High for reported data |
| Valuation | At $48.45 and TTM EPS of $0.76, the trailing P/E is 63.75x. EV/Revenue is roughly 3.2x. The valuation implies aggressive future growth and margin improvement that the Q2 2026 results did not support. | High for math, medium for forward value |
| Technical trend | The stock is in a strong uptrend, up 86% YTD and 53% over the past year. It recently hit an all-time high of $51.34 on July 8, 2026, before pulling back to $48.45. Momentum is positive but extended. | Medium |
| Risk level | Risk is medium-high due to for-profit education regulatory risk, enrollment sensitivity to economic conditions, margin pressure from campus expansion costs, competitive threats, and the premium valuation. | Medium-high |
| AI confidence | Reported financial data is well documented from multiple sources. Future earnings visibility is low because enrollment trends, regulatory changes, and margin trajectories are difficult to predict from public data alone. | High data confidence |
| Investment certainty | Low-medium certainty. The page supports a research process, not a buy or sell decision. The premium multiple requires sustained enrollment and margin improvement that the latest quarterly results have not yet demonstrated. | Low-medium |
UTI AI stock forecast
The UTI AI stock forecast uses three-year scenario ranges from the July 10, 2026 quote, TTM GAAP EPS of $0.76, and explicit earnings-multiple assumptions. It is a scenario tool, not a price promise. The ranges change if enrollment trends, tuition pricing, margins, regulatory conditions, or the market valuation multiple changes.
$58.80 or higher
More likely if enrollment growth accelerates in both UTI and Concorde segments, operating margins recover toward historical levels, EPS compounds near 15% annually, and the market maintains a 55x+ P/E multiple reflecting sustained demand for skilled-trades education.
About $39.50
More likely if enrollment grows at a mid-single-digit pace, margins stabilize but do not expand significantly, EPS grows near 10% annually, and the P/E multiple contracts toward 40x as growth normalizes.
About $22.80
More likely if regulatory scrutiny on for-profit education increases, enrollment decelerates due to economic recovery reducing demand for retraining, margins compress from campus investments, and the P/E multiple falls toward 30x.
UTI AI technical analysis
UTI AI technical analysis uses the $48.45 July 10, 2026 quote and public technical reference points. This static page cannot fetch live chart data. All support, resistance, moving averages, momentum, and volatility levels must be rechecked in a current chart before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $48.45 | Public quote snapshot at the July 10, 2026 data cutoff. Stock pulled back from its all-time high of $51.34. |
| Near support | $44.00 to $46.00 | Recent consolidation area and prior resistance turned support. A loss of this zone would require a fresh chart review. |
| Near resistance | $50.00 to $51.34 | The round number $50 and the all-time high of $51.34 (July 8, 2026) define the immediate resistance zone. |
| All-time high | $51.34 | Set on July 8, 2026. A breakout above this level with volume would signal continued momentum. |
| 52-week low | $21.29 | The 52-week low from July 2025. The stock has more than doubled from this level. |
| Momentum | Positive but extended | The 86% YTD gain suggests strong upward momentum. RSI may be elevated after the recent rally to all-time highs. |
| Volume | Confirm live volume | Average daily volume is 1.14 million shares. Check for volume confirmation on any breakout or breakdown. |
| Volatility | Elevated | Earnings releases, enrollment updates, and regulatory news can cause sharp price moves. The Q2 earnings miss drove notable volatility. |
| Invalidation | Sustained close below $44.00 | This is a framework trigger, not a guaranteed stop price. Reassess the operating thesis if this level breaks on volume. |
UTI AI trading strategy
The UTI AI trading strategy is a rules-based research framework for a for-profit education company trading at a premium valuation. It is not personalized advice. Position size, loss limits, and a fresh review of live price, volume, enrollment data, and quarterly earnings should come before any action.
If UTI breaks above the $51.34 all-time high with above-average volume and enrollment metrics remain strong, a trend continuation trade could be considered with a trailing stop.
Exit or reassess if the breakout fails and price closes back below $50, or if the next earnings report shows continued margin deterioration.
If UTI pulls back toward the $44.00 to $46.00 support zone, evaluate enrollment data and operating margins before treating it as a buying opportunity given the elevated P/E multiple.
Do not average down without a preset maximum loss and confirmation that the enrollment and margin trends remain intact.
Track UTI's quarterly enrollment starts, revenue per student, operating margins, Concorde segment performance, campus expansion progress, and any regulatory or legislative changes affecting for-profit education.
Reduce exposure if same-school enrollments decline, operating margins trend below 5%, or regulatory risk increases materially.
Investment research summary
Customers (students) pay UTI for technical training that leads to careers in automotive, diesel, collision repair, welding, and skilled trades (UTI segment) or allied health, dental, nursing, and patient care (Concorde segment). The model depends on enrollment demand, tuition pricing, student outcomes, graduation rates, and employer hiring demand.
The moat rests on 60+ years of brand recognition in automotive technical education, 33 campuses across 17 states, industry partnerships with manufacturers, and accreditation. It is moderate because community colleges, online alternatives, apprenticeship programs, and competing for-profit schools provide alternatives for prospective students.
The thesis fails if enrollment demand softens as the economy strengthens (reducing retraining needs), regulatory scrutiny of for-profit education increases (Title IV funding changes, gainful employment rules), campus expansion costs pressure margins, the Concorde segment underperforms, or the premium valuation contracts on any earnings disappointment.
CEO Jerome Grant has led the company since 2019 through the Concorde acquisition and campus expansion. Management's capital allocation focuses on organic campus growth and curriculum investment. The decisive test is whether operating margins can improve from the compressed Q2 2026 level while maintaining enrollment momentum.
Skilled-trades education demand is supported by structural technician shortages in automotive, diesel, and HVAC fields, an aging workforce, and growing awareness of non-college career pathways. Healthcare education demand is supported by demographic trends. The counterforces are economic cycles affecting enrollment, competition from community colleges and online options, and for-profit education regulatory risk.
The $48.45 price equals 63.75x TTM GAAP EPS of $0.76, and roughly 3.2x EV/Revenue. The margin of safety is thin at the current multiple, which requires sustained high growth and margin expansion to justify. The Q2 2026 earnings miss ($0.01 vs $0.25 expected) highlights the earnings risk embedded in the current valuation.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price and market capitalization | $48.45 price, $2.67 billion calculated market cap | Google Finance UTI and TradingView UTI | July 13, 2026 |
| Shares outstanding | 55.06 million shares outstanding; 53.06 million float | TradingView UTI key statistics | July 13, 2026 |
| Fiscal year revenue and net income | $835.62 million revenue, $63.02 million net income (FY ending September 2025) | TradingView UTI financials overview | July 13, 2026 |
| Q2 2026 quarterly results | $221.40 million revenue, $433K net income, $0.01 EPS (missed $0.25 consensus) | Google Finance UTI earnings | July 13, 2026 |
| TTM GAAP EPS and P/E | $0.76 TTM GAAP EPS, 63.75x trailing P/E | Financial rigor tool calculation from price and EPS | July 13, 2026 |
| 52-week high and low | $51.34 (July 8, 2026) to $21.29 | TradingView UTI | July 13, 2026 |
| Analyst consensus | 6 analysts, all Strong Buy; price target range $38.00 to $49.00, average $43.67 | Google Finance UTI analyst ratings | July 13, 2026 |
| Employees and campuses | 4,100 employees, 33 campuses (15 UTI + 18 Concorde) | TradingView UTI profile | July 13, 2026 |
This page is an informational research tool, not investment advice, a solicitation, or a recommendation to buy or sell UTI. Forecasts are scenarios based on available data and assumptions, can be wrong, and should be checked against current filings, live market data, and your own risk assessment.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
